Keyphrases
Vaccine Candidate
100%
Gamma Irradiation
100%
Safety Analysis
100%
Efficacy Analysis
100%
Inactivated SARS-CoV-2 Vaccine
100%
Preclinical Safety
100%
Preclinical Efficacy
100%
Granulocyte Colony-stimulating Factor (G-CSF)
66%
T Cell Response
66%
SARS-CoV-2 Virus
66%
Inactivated SARS-CoV-2
66%
B Cell Response
66%
Vaccine Antigen
66%
COVID-19
33%
T Cells
33%
Novel Virus
33%
COVID-19 Outbreak
33%
Angiotensin-converting Enzyme 2 (ACE2)
33%
Feature Enhancement
33%
Immunogenicity
33%
Challenge Test
33%
Balb C Mice
33%
Inactivated Vaccine
33%
SARS-CoV-2 Vaccine
33%
In Vivo Efficacy
33%
Virus Vaccine
33%
Vaccine Model
33%
Neutralization Activity
33%
Lyophilized Vaccine
33%
Antibody Production
33%
Restimulation
33%
Humanized
33%
Antibody-dependent Enhancement
33%
Peptide Pools
33%
In Vivo Safety
33%
Health Crisis
33%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19 Vaccine
100%
B Cell
50%
T Cell
50%
Granulocyte Macrophage Colony Stimulating Factor
50%
In Vitro
25%
COVID-19
25%
Provocation Test
25%
Virus Vaccine
25%
T-Cell Response
25%
Antibody Production
25%
Neutralization
25%
Gamma Irradiation
25%
Antibody Dependent Enhancement
25%
Immunogenicity
25%
Adjuvant
25%
Inactivated Vaccine
25%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
COVID-19 Vaccine
100%
Granulocyte Macrophage Colony Stimulating Factor
50%
Bagg Albino Mouse
25%
Virus Vaccine
25%
Gamma Irradiation
25%
Antibody Dependent Enhancement
25%
Provocation Test
25%
Inactivated Vaccine
25%
Adjuvant
25%